What’s in a name? For Gilead Sciences (NASDAQ: GILD ) , a few billion dollars.Tenofovir alafenamide and tenofovir disoproxil fumarate may sound similar enough (and also a mouthful), but tenofovir alafenamide, commonly referred to as TAF, is worth a heck of a lot more to Gilead Sciences than tenofovir disoproxil fumarate, which goes by the brand name Viread.
Hey, check out all the research scientist jobs. Post your resume today!
